A drug company’s in-house litigation counsel is entitled to see discovery items designated for “outside counsel eyes only” in a patent infringement case because he is walled off from competitive decision-making, a federal magistrate judge in Trenton has ruled.
Functional, geographic and technological measures put in place to wall him off from his peers are sufficient to grant Robert Vroom of Breckenridge Pharmaceutical Inc. full access to highly confidential discovery materials in a patent infringement suit against his company by Sanofi-Aventis, U.S. Magistrate Judge Lois Goodman ruled Jan. 25.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
